Endocrinology @Point of Care Podcasts

By: @Point of Care
Listen for free

  • Summary

  • Our @Point of Care Endocrinology Podcasts have healthcare experts discussing and providing information related to endocrinology diagnosis, treatment, management, and other important information.
    Copyright 2021 At Point of Care, LLC. All rights reserved.
    Show more Show less
Hygiene & Healthy Living
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action

    S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action
    May 7 2021
    Visit http://morningcommutepodcast.com/SGLT2inhibitors6 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, Dr. James Januzzi and Dr. Silvio Inzucchi discuss the surge in collaboration between primary care physicians, endocrinologists, and cardiologists and the groundswell of cardiometabolic clinics. They attribute this to cardiologists moving beyond the so-called glucocentric view and focusing on how diabetes therapies might help reduce cardiovascular risk as well. Drs. Januzzi and Inzucchi will also discuss the recent guidelines that now incorporate sodium-glucose cotransporter 2 (SGLT-2) inhibitors into clinical pathways.
    Show more Show less
    24 mins
  • S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

    S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection
    May 7 2021

    Visit http://morningcommutepodcast.com/SGLT2inhibitors5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.
    Show more Show less
    24 mins
  • S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

    S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit
    May 7 2021

    Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.
    Show more Show less
    25 mins

What listeners say about Endocrinology @Point of Care Podcasts

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available